UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.824

Sortiert nach

Interventional radiology: a half century of innovation

Radiology, 2014-11, Vol.273 (2 Suppl), p.S75

2014

Link zum Volltext

Verfügbarkeit prüfen

Prostate-Specific Membrane Antigen Radioligand Therapy Using 177Lu-PSMA I&T and 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry

The Journal of nuclear medicine (1978), 2022-08, Vol.63 (8), p.1199-1207

2022

Link zum Volltext

Verfügbarkeit prüfen

Salivary Gland Toxicity of PSMA Radioligand Therapy: Relevance and Preventive Strategies

Journal of Nuclear Medicine, 2018-08, Vol.59 (8), p.1172-1173

2018

Link zum Volltext

Verfügbarkeit prüfen

Neuroendocrine Neoplasms of the Small Bowel and Pancreas

Neuroendocrinology, 2020-05, Vol.110 (6), p.444-476

2020

Link zum Volltext

Verfügbarkeit prüfen

177Lu-PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer patients with a single functioning kidney

The Journal of nuclear medicine (1978), 2019-11, Vol.60 (11), p.1579

2019

Link zum Volltext

Verfügbarkeit prüfen

PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: The Bad Berka Experience Since 2013

Journal of Nuclear Medicine, 2016-10, Vol.57 (Suppl 3), p.97S-104S

2016

Link zum Volltext

Verfügbarkeit prüfen

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience

Theranostics, 2012-01, Vol.2 (5), p.437-447

2012

Link zum Volltext

Verfügbarkeit prüfen

Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients

Journal of Nuclear Medicine, 2019-03, Vol.60 (3), p.377-385

2019

Link zum Volltext

Verfügbarkeit prüfen

Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum

Prasad, Vikas

2024

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy

The lancet oncology, 2020-09, Vol.21 (9), p.e431-e443

2020

Link zum Volltext

Verfügbarkeit prüfen

Burying Mao: Chinese Politics in the Age of Deng Xiaoping - Updated Edition

Baum, Richard

1, 2018

Link zum Volltext

Verfügbarkeit prüfen

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT

European journal of nuclear medicine and molecular imaging, 2010-01, Vol.37 (1), p.67-77

2010

Link zum Volltext

Verfügbarkeit prüfen

Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms

Seminars in nuclear medicine, 2012-05, Vol.42 (3), p.190-207

2012

Link zum Volltext

Verfügbarkeit prüfen

Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results

Journal of Nuclear Medicine, 2017-01, Vol.58 (1), p.75-80

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

European journal of nuclear medicine and molecular imaging, 2015-01, Vol.42 (1), p.5-19

2015

Link zum Volltext

Verfügbarkeit prüfen

Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose

The Journal of infectious diseases, 2016-07, Vol.214 (1), p.16-22

2016

Link zum Volltext

Verfügbarkeit prüfen

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

European journal of nuclear medicine and molecular imaging, 2024-03, Vol.51 (4), p.1136-1146

2024

Link zum Volltext

Verfügbarkeit prüfen

First-in-Humans Study of the SSTR Antagonist 177 Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy

Journal of Nuclear Medicine, 2021-11, Vol.62 (11), p.1571-1581

2021

Link zum Volltext

Verfügbarkeit prüfen

First-in-Humans Study of the SSTR Antagonist 177Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy

The Journal of nuclear medicine (1978), 2021-11, Vol.62 (11), p.1571-1581

2021

Link zum Volltext

Verfügbarkeit prüfen

Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS

Dalton transactions : an international journal of inorganic chemistry, 2011-01, Vol.40 (23), p.6104-6111

2011

Link zum Volltext

Verfügbarkeit prüfen

The ICPO Foundation—on the way toward collaborative growth of theranostics

European journal of nuclear medicine and molecular imaging, 2022, Vol.49 (2), p.443-444

2022

Link zum Volltext

Verfügbarkeit prüfen

Prostate-Specific Membrane Antigen Radioligand Therapy Using 177 Lu-PSMA I&T and 177 Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry

Journal of Nuclear Medicine, 2022-08, Vol.63 (8), p.1199-1207

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety of High-Dose Botulinum Toxin Injections for Parotid and Submandibular Gland Radioprotection

Toxins, 2022-01, Vol.14 (1), p.64

2022

Link zum Volltext

Verfügbarkeit prüfen

Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen

British journal of radiology, 2018-11, Vol.91 (1091), p.20180308-20180308

2018

Link zum Volltext

Verfügbarkeit prüfen

Imaging of Neuroendocrine Tumors

Seminars in nuclear medicine, 2006-07, Vol.36 (3), p.228-247

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.824

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.312)
Mit Volltextzugriff
(1.576)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(668)
Life Sciences & Biomedicine
(560)
Humans
(524)
Male
(257)
Female
(246)
Animals
(172)
Middle Aged
(168)
Biological And Medical Sciences
(163)
Adult
(156)
Aged
(141)
Radiology, Nuclear Medicine & Medical Imaging
(133)
Medical Sciences
(132)
Biology
(121)
Biological Sciences
(117)
Evolution
(116)
Evolutionary Biology
(112)
Evolutionary Studies
(109)
Social Sciences
(102)
Genetics
(93)
Physical Sciences
(89)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Interventional radiology: a half century of innovation

Prostate-Specific Membrane Antigen Radioligand Therapy Using 177Lu-PSMA I&T and 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry

Salivary Gland Toxicity of PSMA Radioligand Therapy: Relevance and Preventive Strategies

Neuroendocrine Neoplasms of the Small Bowel and Pancreas

177Lu-PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer patients with a single functioning kidney

PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: The Bad Berka Experience Since 2013

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience

Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients

Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum

Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy

Burying Mao: Chinese Politics in the Age of Deng Xiaoping - Updated Edition

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT

Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms

Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results

Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose

Extended peptide receptor radionuclide therapy: evaluating nephrotoxicity and therapeutic effectiveness in neuroendocrine tumor patients receiving more than four treatment cycles

First-in-Humans Study of the SSTR Antagonist 177 Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy

First-in-Humans Study of the SSTR Antagonist 177Lu-DOTA-LM3 for Peptide Receptor Radionuclide Therapy in Patients with Metastatic Neuroendocrine Neoplasms: Dosimetry, Safety, and Efficacy

Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS

The ICPO Foundation—on the way toward collaborative growth of theranostics

Prostate-Specific Membrane Antigen Radioligand Therapy Using 177 Lu-PSMA I&T and 177 Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: Comparison of Safety, Biodistribution, and Dosimetry

Safety of High-Dose Botulinum Toxin Injections for Parotid and Submandibular Gland Radioprotection

Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen

Imaging of Neuroendocrine Tumors

Suchergebnisse filtern